Social Media Content Creators Fueling Parallel Trade for Unlicensed Weight-Loss Drug

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Some experts said the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Material Removal

Based on the social media company, the service has removed problematic material and banned related hashtags and query recommendations. The company stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Digital Trading Operations

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, positive reviews and detailed guides for mixing or administering at residence.

After minutes of entering one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Item Details and Pricing

Within these communities, messages display black plastic parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.